Literature DB >> 8149957

A novel, complement factor H-related regulatory protein expressed on the surface of human B cell lines.

A Erdei1, N Julen, P Marschang, E Feifel, K Kerekes, M P Dierich.   

Abstract

Complement regulatory proteins present on the surface of various mammalian cells play an important role in controlling homologous lysis, by interacting with C3 (and usually C4). These proteins have a similar structural motif ("short consensus repeat") (Reid, K.B.M., Bentley, R.D., Campbell, R.D., Chung, L.P., Sim, R.B., Kristensen, T. and Tack, B.F., Immunol. Today 1986. 7:230), and the genes encoding them are members of the family of regulators of complement activation. Here we describe a hitherto unknown member of this family, a molecule expressed by B lymphoblastoid cells. This protein is recognized by polyclonal antibodies to factor H and by MAH4, a monoclonal antibody reacting with the N-terminal portion of factor H. The cell surface protein is built up of two disulfide-linked chains of approximately 68 and 75 kDa. Biosynthetic labeling studies confirmed that it is synthesized by B cells only, but not by the investigated lines of other origin. When tested for its functional activity, this molecule was shown to act as cofactor for factor I-mediated cleavage of fluid-phase C3b to C3bi. The protein appears to be encoded by a 3.5-kb mRNA, hybridizing with a cDNA probe coding for the N-terminal portion of factor H. Due to its cross-reactivity with anti-H antibodies, cofactor activity for factor I and hybridization with factor H cDNA, despite its two-chain composition, it is considered a factor H-like protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149957     DOI: 10.1002/eji.1830240414

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Identification of human complement factor H as a chemotactic protein for monocytes.

Authors:  K Nabil; B Rihn; M C Jaurand; J M Vignaud; J Ripoche; Y Martinet; N Martinet
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

2.  Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration.

Authors:  Sven Magnus Hector; Torben Lykke Sørensen
Journal:  Clin Ophthalmol       Date:  2017-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.